NGVT Ingevity Corp

Price (delayed)

$72.77

Market cap

$2.86B

P/E Ratio

21.85

Dividend/share

N/A

EPS

$3.33

Enterprise value

$3.92B

Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, ...

Highlights
NGVT's gross profit is up by 19% YoY
The company's revenue rose by 16% YoY and by 3.4% QoQ
NGVT's P/E is 23% above its last 4 quarters average of 17.8 but 14% below its 5-year quarterly average of 25.4
The quick ratio has contracted by 9% YoY but it has grown by 2.3% from the previous quarter
NGVT's net income is down by 35% QoQ and by 25% YoY
The EPS is down by 35% since the previous quarter and by 23% year-on-year

Key stats

What are the main financial stats of NGVT
Market
Shares outstanding
39.29M
Market cap
$2.86B
Enterprise value
$3.92B
Valuations
Price to earnings (P/E)
21.85
Price to book (P/B)
4.46
Price to sales (P/S)
2.08
EV/EBIT
15.89
EV/EBITDA
10.52
EV/Sales
2.84
Earnings
Revenue
$1.38B
EBIT
$246.4M
EBITDA
$372.1M
Free cash flow
$272.8M
Per share
EPS
$3.33
Free cash flow per share
$6.9
Book value per share
$16.31
Revenue per share
$34.95
TBVPS
$41.52
Balance sheet
Total assets
$2.43B
Total liabilities
$1.78B
Debt
$1.33B
Equity
$644.5M
Working capital
$472.7M
Liquidity
Debt to equity
2.06
Current ratio
2.91
Quick ratio
1.8
Net debt/EBITDA
2.84
Margins
EBITDA margin
26.9%
Gross margin
38.8%
Net margin
9.8%
Operating margin
23.1%
Efficiency
Return on assets
5.7%
Return on equity
20.5%
Return on invested capital
10.2%
Return on capital employed
11.3%
Return on sales
17.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NGVT stock price

How has the Ingevity stock price performed over time
Intraday
-0.07%
1 week
-2.06%
1 month
-8.29%
1 year
6.56%
YTD
-3.91%
QTD
1.96%

Financial performance

How have Ingevity's revenue and profit performed over time
Revenue
$1.38B
Gross profit
$535.2M
Operating income
$319.1M
Net income
$134.8M
Gross margin
38.8%
Net margin
9.8%
The net margin is down by 37% from the previous quarter and by 35% YoY
NGVT's net income is down by 35% QoQ and by 25% YoY
Ingevity's operating income has increased by 22% YoY but it has decreased by 2.1% from the previous quarter
NGVT's gross profit is up by 19% YoY

Growth

What is Ingevity's growth rate over time

Valuation

What is Ingevity stock price valuation
P/E
21.85
P/B
4.46
P/S
2.08
EV/EBIT
15.89
EV/EBITDA
10.52
EV/Sales
2.84
The EPS is down by 35% since the previous quarter and by 23% year-on-year
NGVT's P/E is 23% above its last 4 quarters average of 17.8 but 14% below its 5-year quarterly average of 25.4
The P/B is 51% below the 5-year quarterly average of 9.1 and 5% below the last 4 quarters average of 4.7
The equity has contracted by 6% from the previous quarter but it has grown by 4.5% YoY
NGVT's P/S is 23% below its 5-year quarterly average of 2.7 and 13% below its last 4 quarters average of 2.4
The company's revenue rose by 16% YoY and by 3.4% QoQ

Efficiency

How efficient is Ingevity business performance
The ROE has declined by 38% year-on-year and by 36% since the previous quarter
The ROA has contracted by 37% from the previous quarter and by 29% YoY
The ROS is down by 30% since the previous quarter and by 22% year-on-year
Ingevity's ROIC has decreased by 28% from the previous quarter and by 8% YoY

Dividends

What is NGVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NGVT.

Financial health

How did Ingevity financials performed over time
The total assets is 36% greater than the total liabilities
The company's current ratio fell by 13% YoY
The quick ratio has contracted by 9% YoY but it has grown by 2.3% from the previous quarter
The debt is 106% more than the equity
Ingevity's debt to equity has increased by 7% from the previous quarter but it has decreased by 6% YoY
The equity has contracted by 6% from the previous quarter but it has grown by 4.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.